CVE-2023-27868

IBM Db2 code execution

Description

IBM Db2 JDBC Driver for Db2 for Linux, UNIX and Windows 10.5, 11.1, and 11.5 could allow a remote authenticated attacker to execute arbitrary code on the system, caused by an unchecked class instantiation when providing plugin classes. By sending a specially crafted request using the named pluginClassName class, an attacker could exploit this vulnerability to execute arbitrary code on the system. IBM X-Force ID: 249516.

Category

6.3
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.26%
Vendor Advisory ibm.com Vendor Advisory ibmcloud.com
Affected: IBM Db2 for Linux, UNIX and Windows
Published at:
Updated at:

References

Link Tags
https://www.ibm.com/support/pages/node/7010029 patch vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/249516 vdb entry vendor advisory
https://security.netapp.com/advisory/ntap-20230803-0006/

Frequently Asked Questions

What is the severity of CVE-2023-27868?
CVE-2023-27868 has been scored as a medium severity vulnerability.
How to fix CVE-2023-27868?
To fix CVE-2023-27868, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-27868 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-27868 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-27868?
CVE-2023-27868 affects IBM Db2 for Linux, UNIX and Windows.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.